21 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
our innovative approach and ability to create better biologics faster, along with the scalability of our platform, will enable us to build … the challenges faced by the many companies that are investing in developing innovative new protein-based medicines. As we continue to establish our
8-K
EX-99.1
ABSI
Absci Corp
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
of our AI Integrated Drug Creation™ platform, as we entered into an innovative new collaboration with Almirall and proudly unveiled our internal pipeline
8-K
EX-99.2
ABSI
Absci Corp
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
commitment to target innovative approaches to help patients suffering from severe skin diseases to achieve their dream of leading a healthy life … medical dermatology products to bring our innovative solutions to patients in need.
The company, founded in 1944 and headquartered in Barcelona
8-K
EX-99.1
azhv97 c7edpentm
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
8-K
EX-99.2
dxkvc2u 2c7jg23g0e
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
8-K
EX-99.1
a29fe 9jc5u
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
ARS
8vx7q6z
28 Apr 23
Annual report to shareholders
12:00am
8-K
EX-99.1
vlo49a
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
10-K
qtnvyw bu
22 Mar 22
Annual report
5:20pm
10-Q
ohwvoise al5zp
7 Sep 21
Quarterly report
8:48am
424B4
fxfw ame7h
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
7k6mo 98f9
8 Jul 21
IPO registration (amended)
5:04pm
S-1
n7unj
30 Jun 21
IPO registration
3:20pm
DRS/A
ub7i3pgj1tmr1tyicq1j
16 Jun 21
Draft registration statement (amended)
12:00am